Along with researchers in the Faculty of Health Sciences and the Faculty of Science, Western projects received a total of $17 ...

Can we fix errors in our genetic blueprint that lead to debilitating disorders like Huntington's disease?How can we better support newcomers to Canada ...

Boosting communication between the spinal nerves and the muscles using the spinal cord stimulation reverses spinal muscle atrophy (SMA) progression and could be applied to other motoneuron diseases, ...

PTC Therapeutics, Inc. (NASDAQ:PTCT), a biopharmaceutical company focused on developing and commercializing novel medicines for rare disorders, finds itself at a critical juncture. With a promising ...

Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while ...

Claudia Patino Tarlow Claudia Patino Tarlow, of Sag Harbor, died on January 10 after struggling for a decade battling ...

Other letters look at Medical Aid in Dying, cryptocurrency mining, climate change policies, and national politics ...

Dr. Michael Rezak, MD, Ph.D., DBe, is a renowned neurologist specializing in the treatment of complex movement disorders such as Parkinson's Disease, ...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal ...

“A Complete Unknown” portrays Woody Guthrie, dying in his bed of Huntington’s disease, as a bedrock of authenticity as well ...

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

Reports Q4 revenue $627.7M, consensus $629.44M. “I’m proud of the tremendous progress we made last year with the continued growth of INGREZZA ...